Enantioselective Total Synthesis of (−)‐Finerenone Using Asymmetric Transfer Hydrogenation

Abstract: (−)‐Finerenone is a nonsteroidal mineralocorticoid receptor antagonist currently in phase III clinical trials for the treatment of chronic kidney disease in type 2 diabetes. It contains an unusual dihydronaphthyridine core. We report a 6‐step synthesis of (−)‐finerenone, which features an enantioselective partial transfer hydrogenation of a naphthyridine using a chiral phosphoric acid catalyst with a Hantzsch ester. The process is complicated by the fact that the naphthyridine exists as a mixture of two atropisomers that react at different rates and with different selectivities. The intrinsic kinetic resolution was converted into a kinetic dynamic resolution at elevated temperature, which enabled us to obtain (−)‐finerenone in both high yield and high enantioselectivity. DFT calculations have revealed the origin of selectivity.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Enantioselective Total Synthesis of (−)‐Finerenone Using Asymmetric Transfer Hydrogenation ; volume:59 ; number:51 ; year:2020 ; pages:23107-23111 ; extent:5
Angewandte Chemie / International edition. International edition ; 59, Heft 51 (2020), 23107-23111 (gesamt 5)

Creator
Lerchen, Andreas
Gandhamsetty, Narasimhulu
Farrar, Elliot H. E.
Winter, Nils
Platzek, Johannes
Grayson, Matthew N.
Aggarwal, Varinder K.

DOI
10.1002/anie.202011256
URN
urn:nbn:de:101:1-2022061112313561079527
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Lerchen, Andreas
  • Gandhamsetty, Narasimhulu
  • Farrar, Elliot H. E.
  • Winter, Nils
  • Platzek, Johannes
  • Grayson, Matthew N.
  • Aggarwal, Varinder K.

Other Objects (12)